rs121908489
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_003919.3(SGCE):c.289C>T(p.Arg97*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000274 in 1,459,468 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_003919.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGCE | NM_003919.3 | c.289C>T | p.Arg97* | stop_gained | Exon 3 of 11 | ENST00000648936.2 | NP_003910.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 249940Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135112
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1459468Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726018
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Myoclonic dystonia 11 Pathogenic:7
- -
- -
- -
The c.289C>T;p.(Arg97*) variant creates a premature translational stop signal in the SGCE gene. It is expected to result in an absent or disrupted protein product - PVS1. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 5768; PMID: 11528394; PMID: 15389977; PMID: 17296918; PMID: 18205193; PMID: 15728306)PS4. The variant is present at low allele frequencies population databases (rs121908489 – gnomAD 0.00004001%; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2_supporting. The variant co-segregated with disease in multiple affected family members (PMID: 11528394) - PP1. In summary, the currently available evidence indicates that the variant is pathogenic -
- -
The SGCE c.289C>T (p.Arg97Ter) variant is a stop-gained variant that is predicted to result in a premature truncation of the protein. Across a selection of the available literature, the p.Arg97Ter variant has been identified in at least four individuals with a myoclonus-dystonia phenotype (Zimprich et al. 2001; O'Riordan et al. 2004; Valente et al. 2005; Grünewald et al. 2008). In addition, this variant segregated with the phenotype in three individuals from a large multigenerational family (Zimprich et al. 2001). This variant is found at a frequency of 0.000009 in the European (non-Finnish) population of the Genome Aggregation Database, though this is based on one allele in a region of good sequencing coverage, so the variant is presumed to be rare. Based on the collective evidence and the application of the ACMG criteria, the p.Arg97Ter variant is classified as pathogenic for myoclonus-dystonia. -
This sequence change creates a premature translational stop signal (p.Arg97*) in the SGCE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCE are known to be pathogenic (PMID: 12821748, 15389977, 17853490, 24297365). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with myoclonus-dystonia (PMID: 11528394, 15389977, 15728306, 17296918, 18205193). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 5768). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:3
- -
- -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 18175340, 27363292, 17702043, 19117362, 23332219, 19261534, 25525159, 11528394, 18355305, 18205193, 15728306, 15389977, 33098801, 35925398, 35872528, 35041927, 9750929, 17296918, 23748201) -
Inborn genetic diseases Pathogenic:1
- -
SGCE-related disorder Pathogenic:1
The SGCE c.289C>T variant is predicted to result in premature protein termination (p.Arg97*). This variant has been reported in multiple unrelated individuals with myoclonus dystonia (Zimprich et al 2001. PubMed ID: 11528394; Zech et al 2020. PubMed ID: 33098801; Wu et al 2022. PubMed ID: 35041927). This variant is reported in 0.00089% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-94257615-G-A). Nonsense variants in SGCE are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at